AU · rank #1 · 2026-09-08
SNT
GPW · PLN · $779M (USD)
The exact numbers the algorithm saw.
| Composite score Z-score blend of all factors below. | 2.497 |
|---|---|
| EPS revisions (30d) Change in consensus EPS estimate over the past 30 days ($/share). | +$2.35 |
| Net revisions (30d) Number of analysts revising upward minus downward. | 1 |
| Insider signal (90d) | — |
| Analyst upside Consensus target $373.00 | +10.2% |
| Momentum acceleration 3-month minus 12-month momentum. | +9.24% |
| Analyst rating 5 = Strong Buy, 1 = Strong Sell. | — |
| Gross margin TTM | +23.5% |
| 52w high | $398.40 |
| Market cap (USD) | $779M |
The AI research card
Independent qualitative review of each pick before the order is placed. On the rare day the research service is unavailable, the paper book trades on the quant ranking alone and no card appears here.
Summary
Synektik is a Polish nuclear medicine and diagnostic imaging group combining equipment distribution with radiopharmaceutical supply and recurring service contracts, generating ~334M PLN in trailing recurring revenue growing 52% YoY.
Rationale
100% analyst revision agreement, a positive EPS revision trend sustained across 7/30/60/90-day windows, and 10% analyst upside on a name with accelerating revenue momentum (+89% YoY in Q3) directly reinforce the analyst_upside strategy's logic of riding consensus upgrades into a fundamentally improving story.
Material risks
- 1With only 3 analysts covering SNT, the 100% revision agreement and 10% upside signal are highly concentrated — a single estimate change could collapse the signal, and the 25.7% target dispersion already flags meaningful disagreement on fair value.
- 2The large non-cash Syn2bio spin-off gain (~261M PLN) distorts reported net profit, and if analysts are anchoring EPS revisions to inflated headline earnings rather than continuing-operations profitability (~83M PLN H1), the revision quality is weaker than the signal implies.
AI verdict council
Each pick is reviewed independently by 3 models before any order. 3 of 3 voted to proceed.